Weight loss pill maker Epitomees stock sinks 70 percent after Nestl cancels agreement - CTech
| EPIT Stock | 947.50 10.50 1.10% |
About 61% of Epitomee Medical's investor base is looking to short. The analysis of current outlook of investing in Epitomee Medical suggests that many traders are alarmed regarding Epitomee Medical's prospects. The current market sentiment, together with Epitomee Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Epitomee Medical stock news signals to limit their universe of possible portfolio assets.
Epitomee |
Weight loss pill maker Epitomees stock sinks 70 percent after Nestl cancels agreement CTech
Read at news.google.com
 |
Epitomee Medical Fundamental Analysis
We analyze Epitomee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epitomee Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epitomee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Epitomee Medical is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Epitomee Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Epitomee Medical stock to make a market-neutral strategy. Peer analysis of Epitomee Medical could also be used in its relative valuation, which is a method of valuing Epitomee Medical by comparing valuation metrics with similar companies.
Peers
Epitomee Medical Related Equities
| ALLT | Allot Communications | 3.23 | ||||
| RSEL | RSL Electronics | 2.97 | ||||
| ELWS | Electreon Wireless | 0.97 | ||||
| ORON | Oron Group | 0.49 | ||||
| MGDL | Migdal Insurance | 0.60 | ||||
| MTDS | Meitav Dash | 0.73 | ||||
| ISRS | Isras Investment | 1.43 |
Complementary Tools for Epitomee Stock analysis
When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |